Prognostic Value of Parkinson's Disease Subtypes in the LABS ‐ PD Cohort: Functional Ability, Quality of Life and Mortality

Documenti analoghi

• Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study ( iCARE ‐ PD )
  di: Deepa Dash, et al.
  Pubblicazione: (2025)
• Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease
  di: Daniel Weintraub, et al.
  Pubblicazione: (2024)
• Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach
  di: Connie Marras, et al.
  Pubblicazione: (2024)
• Is Parkinson Disease Better Defined Solely by Biology or as a Clinical–Biological Entity? Lessons to be Learned from Alzheimer's Disease on Biological Definition and Staging
  di: Tiago A. Mestre, et al.
  Pubblicazione: (2025)
• Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial
  di: Diana Koszycki, et al.
  Pubblicazione: (2024)